Clinical trials with a new dermatologic solution.
D000208:Acute Disease; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002908:Chronic Disease; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D008297:Male; D009355:Neomycin / Q000627:therapeutic use; D010032:Otitis Externa / Q000188:drug therapy / Q000662:veterinary; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000662:veterinary; D012874:Skin Diseases, Infectious / Q000188:drug therapy / Q000662:veterinary*; D013827:Thiabendazole / Q000627:therapeutic use
D000891:Anti-Infective Agents, Local; D003879:Dermatologic Agents; D004338:Drug Combinations; D003907:Dexamethasone; D009355:Neomycin; D013827:Thiabendazole